Molecular Epidemiology of Colonizing and Infecting Isolates of Klebsiella pneumoniae
- PMID: 27777984
- PMCID: PMC5071533
- DOI: 10.1128/mSphere.00261-16
Molecular Epidemiology of Colonizing and Infecting Isolates of Klebsiella pneumoniae
Abstract
Klebsiella pneumoniae is among the most common causes of hospital-acquired infections and has emerged as an urgent threat to public health due to carbapenem antimicrobial resistance. K. pneumoniae commonly colonizes hospitalized patients and causes extraintestinal infections such as urinary tract infection, bloodstream infection (septicemia), and pneumonia. If colonization is an intermediate step before infection, then detection and characterization of colonizing isolates could enable strategies to prevent or empirically treat K. pneumoniae infections in hospitalized patients. However, the strength of the association between colonization and infection is unclear. To test the hypothesis that hospitalized patients become infected with their colonizing strain, 1,765 patients were screened for rectal colonization with K. pneumoniae, and extraintestinal isolates from these same patients were collected over a 3-month period in a cohort study design. The overall colonization prevalence was 23.0%. After adjustment for other patient factors, colonization was significantly associated with subsequent infection: 21 of 406 (5.2%) colonized patients later had extraintestinal infection, compared to 18 of 1,359 (1.3%) noncolonized patients (adjusted odds ratio [OR], 4.01; 95% confidence interval, 2.08 to 7.73; P < 0.001). Despite a high diversity of colonizing isolates, 7/7 respiratory, 4/4 urinary, and 2/5 bloodstream isolates from colonized patients matched the patient corresponding rectal swab isolates, based on wzi capsular typing, multilocus sequence typing (MLST), and whole-genome sequence analysis. These results suggest that K. pneumoniae colonization is directly associated with progression to extraintestinal infection. IMPORTANCE K. pneumoniae commonly infects hospitalized patients, and these infections are increasingly resistant to carbapenems, the antibiotics of last resort for life-threatening bacterial infections. To prevent and treat these infections, we must better understand how K. pneumoniae causes disease and discover new ways to predict and detect infections. This study demonstrates that colonization with K. pneumoniae in the intestinal tract is strongly linked to subsequent infection. This finding helps to identify a potential time frame and possible approach for intervention: the colonizing strain from a patient could be isolated as part of a risk assessment, and antibiotic susceptibility testing could guide empirical therapy if the patient becomes acutely ill.
Keywords: Klebsiella; MLST; cgMLST; colonization; infection; pneumonia; whole-genome sequencing; wzi.
Figures




Comment in
-
Genome watch: Klebsiella pneumoniae: when a colonizer turns bad.Nat Rev Microbiol. 2017 Jul;15(7):384. doi: 10.1038/nrmicro.2017.64. Epub 2017 Jun 5. Nat Rev Microbiol. 2017. PMID: 28579608 No abstract available.
Similar articles
-
Association between Intestinal Colonization and Extraintestinal Infection with Carbapenem-Resistant Klebsiella pneumoniae in Children.Microbiol Spectr. 2023 Mar 14;11(2):e0408822. doi: 10.1128/spectrum.04088-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36916927 Free PMC article.
-
The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.J Infect Dis. 2020 Mar 16;221(Suppl 2):S206-S214. doi: 10.1093/infdis/jiz622. J Infect Dis. 2020. PMID: 32176790
-
Risk Factors for Klebsiella Infections among Hospitalized Patients with Preexisting Colonization.mSphere. 2021 Jun 30;6(3):e0013221. doi: 10.1128/mSphere.00132-21. Epub 2021 Jun 23. mSphere. 2021. PMID: 34160237 Free PMC article.
-
Prevalence and incidence of carbapenem-resistant K. pneumoniae colonization: systematic review and meta-analysis.Syst Rev. 2022 Nov 15;11(1):240. doi: 10.1186/s13643-022-02110-3. Syst Rev. 2022. PMID: 36380387 Free PMC article.
-
Molecular basis of Klebsiella pneumoniae colonization in host.Microb Pathog. 2023 Apr;177:106026. doi: 10.1016/j.micpath.2023.106026. Epub 2023 Feb 10. Microb Pathog. 2023. PMID: 36773942 Review.
Cited by
-
Gut Microbiota Modulation: Implications for Infection Control and Antimicrobial Stewardship.Adv Ther. 2020 Oct;37(10):4054-4067. doi: 10.1007/s12325-020-01458-z. Epub 2020 Aug 7. Adv Ther. 2020. PMID: 32767183 Free PMC article. Review.
-
First Belgian Report of Ertapenem Resistance in an ST11 Klebsiella Pneumoniae Strain Isolated from a Dog Carrying blaSCO-1 and blaDHA-1 Combined with Permeability Defects.Antibiotics (Basel). 2022 Sep 15;11(9):1253. doi: 10.3390/antibiotics11091253. Antibiotics (Basel). 2022. PMID: 36140031 Free PMC article.
-
Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.PLoS One. 2018 Sep 6;13(9):e0203143. doi: 10.1371/journal.pone.0203143. eCollection 2018. PLoS One. 2018. PMID: 30188914 Free PMC article.
-
Analysis of Risk Factors and Mortality of Patients with Carbapenem-Resistant Klebsiella pneumoniae Infection.Infect Drug Resist. 2022 May 3;15:2383-2391. doi: 10.2147/IDR.S362723. eCollection 2022. Infect Drug Resist. 2022. PMID: 35535031 Free PMC article.
-
High Prevalence of Klebsiella pneumoniae in European Food Products: a Multicentric Study Comparing Culture and Molecular Detection Methods.Microbiol Spectr. 2022 Feb 23;10(1):e0237621. doi: 10.1128/spectrum.02376-21. Epub 2022 Feb 23. Microbiol Spectr. 2022. PMID: 35196810 Free PMC article.
References
-
- Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK. 2014. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370:1198–1208. doi:10.1056/NEJMoa1306801. - DOI - PMC - PubMed
-
- CDC 2014. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources